Literature DB >> 21737877

Modulation of subthalamic T-type Ca(2+) channels remedies locomotor deficits in a rat model of Parkinson disease.

Chun-Hwei Tai1, Ya-Chin Yang, Ming-Kai Pan, Chen-Syuan Huang, Chung-Chin Kuo.   

Abstract

An increase in neuronal burst activities in the subthalamic nucleus (STN) is a well-documented electrophysiological feature of Parkinson disease (PD). However, the causal relationship between subthalamic bursts and PD symptoms and the ionic mechanisms underlying the bursts remain to be established. Here, we have shown that T-type Ca(2+) channels are necessary for subthalamic burst firing and that pharmacological blockade of T-type Ca(2+) channels reduces motor deficits in a rat model of PD. Ni(2+), mibefradil, NNC 55-0396, and efonidipine, which inhibited T-type Ca(2+) currents in acutely dissociated STN neurons, but not Cd(2+) and nifedipine, which preferentially inhibited L-type or the other non–T-type Ca(2+) currents, effectively diminished burst activity in STN slices. Topical administration of inhibitors of T-type Ca(2+) channels decreased in vivo STN burst activity and dramatically reduced the locomotor deficits in a rat model of PD. Cd(2+) and nifedipine showed no such electrophysiological and behavioral effects. While low-frequency deep brain stimulation (DBS) has been considered ineffective in PD, we found that lengthening the duration of the low-frequency depolarizing pulse effectively improved behavioral measures of locomotion in the rat model of PD, presumably by decreasing the availability of T-type Ca(2+) channels. We therefore conclude that modulation of subthalamic T-type Ca(2+) currents and consequent burst discharges may provide new strategies for the treatment of PD.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21737877      PMCID: PMC3223922          DOI: 10.1172/JCI46482

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Increased subthalamic neuronal activity after nigral dopaminergic lesion independent of disinhibition via the globus pallidus.

Authors:  O K Hassani; M Mouroux; J Féger
Journal:  Neuroscience       Date:  1996-05       Impact factor: 3.590

Review 2.  Low-threshold calcium currents in central nervous system neurons.

Authors:  J R Huguenard
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

3.  Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease.

Authors:  P Krack; P Limousin; A L Benabid; P Pollak
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

4.  Molecular characterization of a neuronal low-voltage-activated T-type calcium channel.

Authors:  E Perez-Reyes; L L Cribbs; A Daud; A E Lacerda; J Barclay; M P Williamson; M Fox; M Rees; J H Lee
Journal:  Nature       Date:  1998-02-26       Impact factor: 49.962

Review 5.  Discovery and main pharmacological properties of mibefradil (Ro 40-5967), the first selective T-type calcium channel blocker.

Authors:  J P Clozel; E A Ertel; S I Ertel
Journal:  J Hypertens Suppl       Date:  1997-12

6.  Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.

Authors:  A Benazzouz; T Boraud; J Féger; P Burbaud; B Bioulac; C Gross
Journal:  Mov Disord       Date:  1996-11       Impact factor: 10.338

7.  Single unit analysis of the human ventral thalamic nuclear group. Tremor-related activity in functionally identified cells.

Authors:  F A Lenz; H C Kwan; R L Martin; R R Tasker; J O Dostrovsky; Y E Lenz
Journal:  Brain       Date:  1994-06       Impact factor: 13.501

8.  Central motor loop oscillations in parkinsonian resting tremor revealed by magnetoencephalography.

Authors:  J Volkmann; M Joliot; A Mogilner; A A Ioannides; F Lado; E Fazzini; U Ribary; R Llinás
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

9.  Bilateral subthalamic nucleus stimulation for severe Parkinson's disease.

Authors:  P Limousin; P Pollak; A Benazzouz; D Hoffmann; E Broussolle; J E Perret; A L Benabid
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

10.  The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism.

Authors:  H Bergman; T Wichmann; B Karmon; M R DeLong
Journal:  J Neurophysiol       Date:  1994-08       Impact factor: 2.714

View more
  27 in total

1.  Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine.

Authors:  Claudia Rangel-Barajas; Ana María Estrada-Sánchez; Scott J Barton; Robert R Luedtke; George V Rebec
Journal:  Neuropharmacology       Date:  2016-11-02       Impact factor: 5.250

2.  Neuronal firing patterns outweigh circuitry oscillations in parkinsonian motor control.

Authors:  Ming-Kai Pan; Sheng-Han Kuo; Chun-Hwei Tai; Jyun-You Liou; Ju-Chun Pei; Chia-Yuan Chang; Yi-Mei Wang; Wen-Chuan Liu; Tien-Rei Wang; Wen-Sung Lai; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2016-10-31       Impact factor: 14.808

3.  Locally optimal extracellular stimulation for chaotic desynchronization of neural populations.

Authors:  Dan Wilson; Jeff Moehlis
Journal:  J Comput Neurosci       Date:  2014-06-05       Impact factor: 1.621

4.  Deranged NMDAergic cortico-subthalamic transmission underlies parkinsonian motor deficits.

Authors:  Ming-Kai Pan; Chun-Hwei Tai; Wen-Chuan Liu; Ju-Chun Pei; Wen-Sung Lai; Chung-Chin Kuo
Journal:  J Clin Invest       Date:  2014-09-09       Impact factor: 14.808

5.  Anatomical localization of Cav3.1 calcium channels and electrophysiological effects of T-type calcium channel blockade in the motor thalamus of MPTP-treated monkeys.

Authors:  Annaelle Devergnas; Erdong Chen; Yuxian Ma; Ikuma Hamada; Damien Pittard; Stefan Kammermeier; Ariana P Mullin; Victor Faundez; Craig W Lindsley; Carrie Jones; Yoland Smith; Thomas Wichmann
Journal:  J Neurophysiol       Date:  2015-11-04       Impact factor: 2.714

Review 6.  Targeting voltage-gated calcium channels in neurological and psychiatric diseases.

Authors:  Gerald W Zamponi
Journal:  Nat Rev Drug Discov       Date:  2015-11-06       Impact factor: 84.694

Review 7.  The T-type calcium channel as a new therapeutic target for Parkinson's disease.

Authors:  Ya-Chin Yang; Chun-Hwei Tai; Ming-Kai Pan; Chung-Chin Kuo
Journal:  Pflugers Arch       Date:  2014-02-18       Impact factor: 3.657

8.  Regularizing firing patterns of rat subthalamic neurons ameliorates parkinsonian motor deficits.

Authors:  Qian-Xing Zhuang; Guang-Ying Li; Bin Li; Chang-Zheng Zhang; Xiao-Yang Zhang; Kang Xi; Hong-Zhao Li; Jian-Jun Wang; Jing-Ning Zhu
Journal:  J Clin Invest       Date:  2018-10-29       Impact factor: 14.808

9.  Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-Type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys.

Authors:  Adriana Galvan; Annaelle Devergnas; Damien Pittard; Gunasingh Masilamoni; Jocelyn Vuong; J Scott Daniels; Ryan D Morrison; Craig W Lindsley; Thomas Wichmann
Journal:  ACS Chem Neurosci       Date:  2016-09-20       Impact factor: 4.418

10.  Sex Differences in Electrophysiological Properties of Mouse Medial Preoptic Area Neurons Revealed by In Vitro Whole-cell Recordings.

Authors:  Wen Zhang; Shuai-Shuai Li; Ying Han; Xiao-Hong Xu
Journal:  Neurosci Bull       Date:  2020-09-04       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.